UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

SUBMIT
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI M44

Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline

inactive
Buy Now
Organization: CLSI
Publication Date: 1 August 2009
Status: inactive
Page Count: 40
scope:

With a need to make antifungal susceptibility testing more readily available to the clinical laboratory, CLSI document M44-A2 provides an established methodology for disk diffusion testing of Candida spp.; zone interpretive criteria for caspofungin, fluconazole, and voriconazole; and recommended quality control ranges for caspofungin, fluconazole, posaconazole, and voriconazole.

The method described in this document is intended for testing Candida spp. This method does not currently encompass any other genera and has not been used in studies of the yeast form of dimorphic fungi, such as Blastomyces dermatitidis or Histoplasma capsulatum. Moreover, testing of filamentous fungi (ie, moulds) is not addressed in the current procedure.

The method described herein must be followed exactly to obtain reproducible results. When new problems are recognized or improvements in these criteria are developed, changes will be incorporated into future editions of this guideline and also distributed in periodic informational supplements.

This guideline is intended for use by, but not limited to, health care, academic, government, industry, or independent research organizations that perform antifungal susceptibility testing of yeasts.

Document History

December 1, 2018
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts
This guideline provides an established methodology for disk diffusion testing of select Candida spp. For zone diameter breakpoints, interpretive categories, and recommended QC ranges for caspofungin,...
August 1, 2009
Zone Diameter Interpretive Standards, Corresponding Minimal Inhibitory Concentration (MIC) Interpretive Breakpoints, and Quality Control Limits for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Informational Supplement
A description is not available for this item.
August 1, 2009
Zone Diameter Interpretive Standards, Corresponding Minimal Inhibitory Concentration (MIC) Interpretive Breakpoints, and Quality Control Limits for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Third Informational Supplement
A description is not available for this item.
CLSI M44
August 1, 2009
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline
With a need to make antifungal susceptibility testing more readily available to the clinical laboratory, CLSI document M44-A2 provides an established methodology for disk diffusion testing of Candida...

References

Advertisement